A decrease in the number of functional insulin-producing beta cells is the key factor in the development of T2DM and hyperglycemia, while dyslipidemia, cytokines, leptin, autoimmunity, and some sulfonylureas may contribute to the damage of beta cells 146. The gene discussed is INS; the disease is metabolic syndrome.